Clinical Trial Update: Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker [Phase 4]

View source ↗

Summary

Phase 4 trial comparing anti-obesity phentermine-topiramate extended-release versus placebo in adults using a wearable activity tracker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• phentermine-topiramate extended-release (phentermine-topiramate extended-release)

Snippet

Sponsor: Mayo Clinic | Conditions: Obesity | Phase 4 | Status: COMPLETED | Results posted: 2023-06-22